HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria-Cristina Moldovan-Loomis Selected Research

Therapeutics

2/2010A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies.
5/2009In vitro and in vivo characterization of MDX-1401 for therapy of malignant lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria-Cristina Moldovan-Loomis Research Topics

Disease

2Neoplasms (Cancer)
02/2010 - 05/2009
1Hypersensitivity (Allergy)
11/2018
1Migraine Disorders (Migraine)
11/2018
1Pain (Aches)
11/2018
1Strabismus (Squint)
11/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2010
1Lymphoma (Lymphomas)
05/2009

Drug/Important Bio-Agent (IBA)

1AntibodiesIBA
11/2018
1Calcitonin Gene-Related PeptideIBA
11/2018
1NeuropeptidesIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
11/2018
1MDX-1342 antibodyIBA
02/2010
1MDX-1401IBA
05/2009

Therapy/Procedure

2Therapeutics
02/2010 - 05/2009